Terumo Corporation

4543.T
Medical Instruments & Supplies
2026/08/21 Updated
Market Cap: $23.9B (¥3.8T)
Stock Price: $16.21 (¥2,577)
Exchange Rate: 1 USD = ¥158.98

【Terumo】Enhancing Corporate Value through Stock Option Issuance | July 16, 2026

Terumo plans to issue new stock acquisition rights to management executives and Fellows to drive stock price increases and enhance corporate value. The total allocation is based on planned allotments, with the exercise period from August 5, 2026, to August 4, 2056.

Importance:
Page Updated: July 16, 2026
IR Disclosure Date: July 16, 2026

Key Figures

  • Name of stock acquisition rights: Terumo Corporation 14th Stock Acquisition Rights
  • Allottees: 11 management executives, 1 responsible executive, 2 Fellows
  • Number of shares granted: 8 shares per right

AI要約

Details of Stock Option Issuance

Terumo has resolved at today’s Board of Directors meeting to issue new stock acquisition rights to management executives and Fellows. The total number is based on planned allotments, with an exercise period from August 5, 2026, to August 4, 2056. The purpose is to increase stock price and boost corporate value, with 8 shares granted per right. Adjustments to the number of shares granted may be made in response to stock splits or consolidations.

Impact on Shareholders and Future Outlook

This issuance of stock acquisition rights aims to motivate management to align with stock price movements and promote corporate value enhancement. The long-term exercise period may lead to potential dilution of shares in the future, but the intention is to increase shareholder value through stock price growth. The company will continue implementing measures to enhance corporate value, contributing to shareholder returns and strengthening incentives for management.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Terumo Corporation

Company overview · Stock price · Financial data · All IR

View company page →